Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Initial Results of a Phase 2 Study of Guadecitabine (SGI-110), a Novel Subcutaneous (sc) Hypomethylating Agent, for Patients with Previously Untreated Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)
EPA is known for its anti-inflammatory properties, which can help protect the brain against age-related damage and maintain cognitive function
Uremia and inadequate oxygen supply induce eryptosis and intracellular hypoxia in red blood cells
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes
"Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer"
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
